✦ LIBER ✦

Pancreatic cancer, gene delivery, and targets: The search for specificity

✍ Scribed by Harvey I. Pass

Publisher: Springer
Year: 1998
Tongue: English
Weight: 356 KB
Volume: 5
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02303474

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A recurrent chromosome translocation bre

A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene

✍ José Adélaïde; Huai-En Huang; Anne Murati; Amber E. Alsop; Béatrice Orsetti; Mar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Abstract The 8p11–21 region is a frequent target of alterations in breast cancer and other carcinomas. We surveyed 34 breast tumor cell lines and 9 pancreatic cancer cell lines for alterations of this region by use of multicolor fluorescence in situ hybridization (M‐FISH) and BAC‐specific FISH.

A powerful cooperative interaction betwe

A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors

✍ Xiaohong Zhang; Louise Collins; John W. Fabre 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Background Following receptor-mediated endocytosis, vector/DNA complexes require assistance to exit endocytic vesicles in order to avoid degradation in the lysosomes. Overcoming this barrier is a major challenge for the development of receptor-targeted, non-viral gene delivery. ## Methods The fus

Expression of the mage gene family in pr

Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy

✍ Vincenzo Russo; Catia Traversari; Alessandro Verrecchia; Marcella Mottolese; Pie 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 956 KB

## Abstract Some human tumors express known antigens that can be utilized as targets for specific immunotherapy. An absolute requirement for the efficacy of this therapeutic strategy is an adequate expression of the candidate antigen by all cells of the primary and metastatic tumor. To examine the

Promotability and tissue specificity of

Promotability and tissue specificity of hereditary cancer genes: Do hereditary cancer patients have a reduced requirement for tumor promotion because all their somatic cells are heterozygous at the predisposing locus?

✍ Christos Paraskeva; Ann C. Williams 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

## INITIATION/PROMOTION AND TUMOR SUPPRESSION Two important concepts in carcinogenesis have stimulated major research programs that have led to significant progress in our understanding of the cellular and molecular basis of cancer. The first is the multistage nature of carcinogenesis and the sepa

The inhibitory effect of an EGF receptor

The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I

✍ Masao Kobari; Björn Kullenberg; Anders Björkman; Seiki Matsuno; Ingemar Ihse; Ja 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 860 KB

Imatinib mesylate for targeting the plat

Imatinib mesylate for targeting the platelet-derived growth factor β receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—A dose-escalation Phase I trial

✍ Salah-Eddin Al-Batran; Akin Atmaca; Eberhard Schleyer; Claudia Pauligk; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract ## BACKGROUND. In previous experimental models, because of its ability to inhibit the activity of platelet‐derived growth factor β receptor, imatinib decreased the interstitial fluid pressure and improved the delivery and efficacy of anticancer drugs, including fluorouracil. The object